Literature DB >> 22688939

Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation.

Carl Friedrich Classen1, Dieter Haffner, Christina Hauenstein, Ricarda Wolf, Ulrike Kyank.   

Abstract

Gastrointestinal vascular malformations are a rare cause of acute or chronic blood loss. Usually they are treated by endoscopic obliteration or surgical resection. When such a therapy is inapplicable, pharmacotherapy may be required. At the age of 15 years, our female patient suffered from transfusion dependent recurrent gastrointestinal haemorrhage due to multiple gastrointestinal vascular malformations. Gastroscopy, coloscopy and capsule endoscopy revealed numerous foci making both endoscopic obliteration and complete surgical resection impossible. Neither regular transfusions nor substitution with coagulation factors were helpful. However, subcutaneous octreotide resulted in immediate stop of bleeding. Initial treatment by daily subcutaneous injections was followed by monthly depot application. Over 3 years only 2 transfusions had to be given. The patient required thyroxin substitution, otherwise, no side effects occurred and the girl had a good quality of life. The authors conclude that octreotide is safe and effective in gastrointestinal angiodysplasias inaccessible to endoscopy or surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22688939      PMCID: PMC3171026          DOI: 10.1136/bcr.05.2011.4291

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

Review 1.  Octreotide in pediatric patients.

Authors:  Janice B Heikenen; John F Pohl; Steven L Werlin; John C Bucuvalas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-11       Impact factor: 2.839

2.  Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol.

Authors:  N Krikis; K Tziomalos; V Perifanis; S Vakalopoulou; A Karagiannis; V Garipidou; F Harsoulis
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding.

Authors:  Steven J Fishman; C Jason Smithers; Judah Folkman; Dennis P Lund; Patricia E Burrows; John B Mulliken; Victor L Fox
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

4.  The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.

Authors:  G Nardone; A Rocco; T Balzano; G Budillon
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

5.  A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia.

Authors:  F Junquera; F Feu; M Papo; S Videla; J R Armengol; J M Bordas; E Saperas; J M Piqué; J R Malagelada
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

6.  Gastric angiodysplasia in a child with Bernard-Soulier syndrome: efficacy of octreotide in long-term management.

Authors:  Zühre Kaya; Türkiz Gürsel; Buket Dalgic; Deniz Aslan
Journal:  Pediatr Hematol Oncol       Date:  2005 Apr-May       Impact factor: 1.969

7.  Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.

Authors:  J B Mulliken; J Glowacki
Journal:  Plast Reconstr Surg       Date:  1982-03       Impact factor: 4.730

8.  Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine.

Authors:  F P Rossini; A Arrigoni; M Pennazio
Journal:  Am J Gastroenterol       Date:  1993-09       Impact factor: 10.864

9.  Octreotide therapy for control of acute gastrointestinal bleeding in children.

Authors:  Y Eroglu; K M Emerick; P F Whitingon; E M Alonso
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

10.  Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.

Authors:  T Florio; M Morini; V Villa; S Arena; A Corsaro; S Thellung; M D Culler; U Pfeffer; D M Noonan; G Schettini; A Albini
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

View more
  1 in total

Review 1.  Role of octreotide in small bowel bleeding.

Authors:  Anwar Khedr; Esraa Elaraby Mahmoud; Noura Attallah; Mikael Mir; Sydney Boike; Ibtisam Rauf; Abbas B Jama; Hisham Mushtaq; Salim Surani; Syed A Khan
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.